France's Ipsen has expanded its oncology pipeline by licensing a T-cell engager (TCE) therapy from Paris-based start-up Biomunex Pharmaceuticals. The deal – valued at up to $610 million – focuses on ...
Every founder should have access to data to find their first customers. Every student should have access to data to complete their college research projects. Let's begin. This Google Maps Scraper is ...
Subscribe Login Register Log out My Profile Subscriber Services Search PGe NEWSLETTERS PG STORE ARCHIVES OBITUARIES JOBS PUBLIC NOTICES CLASSIFIEDS EVENTS PETS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback